Abstract:Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) is a kind of inborn errors of metabolism, with the main clinic manifestations of jaundice, hepatomegaly, and abnormal liver function indices. As a mitochondrial solute carrier protein, citrin plays important roles in aerobic glycolysis, gluconeogenesis, urea cycle, and protein and nucleotide syntheses. Therefore citrin deficiency causes various and complicated metabolic disturbances, such as hypoglycemia, hyperlactic acidemia, hyperammonemia, hypoproteinemia, hyperlipidemia, and galactosemia. This paper reported a case of NICCD confirmed by mutation analysis of SLC25A13, the gene encoding citrin. The baby (male, 6 months old) was referred to the First Affiliated Hospital with the complaint of jaundice of the skin and sclera, which it had suffered from for nearly 6 months. Physical examination showed obvious jaundice and a palpable liver 5 cm below the right subcostal margin. Liver function tests revealed elevated enzymatic activities, like GGT, ALP, AST, and ALT, together with increased levels of TBA, bilirubin (especially conjugated bilirubin), and decreased levels of total protein/albumin and fibrinogen. Blood levels of ammonia, lactate, cholesterol, and triglyceride were also increased, and in particular, the serum AFP level reached 319,225.70 microg/L, a extremely elevated value that has rarely been found in practice before. Tandem mass analysis of a dried blood sample revealed increased levels of free fatty acids and tyrosine, methionine, citrulline, and threonine as well. UP-GC-MS analysis of the urine sample showed elevated galactose and galactitol. The baby was thus diagnosed with suspected NICCD based on the findings. It was then treated with oral arginine and multiple vitamins (including fat-soluble vitamins A, D, E, and K), and was fed with lactose-free and medium-chain fatty acids enriched formula instead of breast feeding. After half a month of treatment, the jaundice disappeared, and the laboratory findings, including liver function indices, blood levels of ammonia, lactate and AFP, were returned to normal level. The baby was followed up for 6 months. It developed well, and the abnormal laboratory findings, including MS-MS and UP-GC-MS analysis results, have been corrected, except a slightly elevated lactate level sometimes. SLC25A13 gene mutation analysis for the patient revealed a compound heterozygote of mutation 851del4 and 1638ins23 and therefore NICCD was definitely diagnosed.

Clinical and Genetic Analysis of 26 Chinese Patients with Neonatal Intrahepatic Cholestasis Due to Citrin Deficiency.

Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency: Clinical and Laboratory Investigation of 13 Subjects in Mainland of China

[Analysis of clinical and genetic variation in neonatal intrahepatic cholestasis caused by citrin deficiency]

[Identification and Diagnosis of Three Novel Mutations in SLC25A13 Gene of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency].

Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency: In vivo and in vitro studies of the aberrant transcription arising from two novel splice-site variants in SLC25A13

Clinical, Molecular and Functional Investigation on an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency (NICCD).

Neonatal intrahepatic cholestasis caused by citrin deficiency: a clinicopathological analysis of two cases

SLC25A13 Gene Mutation Analysis in a Pedigree of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency

[A difficult and complicated case study: neonatal intrahepatic cholestasis caused by citrin deficiency]

[Studies on the clinical manifestation and SLC25A13 gene mutation of Chinese patients with neonatal intrahepatic cholestasis caused by citrin deficiency].

Molecular Diagnosis of Pediatric Patients with Citrin Deficiency in China: SLC25A13 Mutation Spectrum and the Geographic Distribution.

Novel mutations in the SLC25A13 gene in a patient with NICCD and severe manifestations.

Molecular Diagnosis of Citrin Deficiency in an Infant with Intrahepatic Cholestasis: Identification of a 21.7kb Gross Deletion That Completely Silences the Transcriptional and Translational Expression of the Affected SLC25A13 Allele.

Clinical and Laboratory Features of 12 Patients with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency

Clinical research of neonatal intrahepatic cholestasis caused by Citrin deficiency in Hubei Province

SLC25A13 Cdna Cloning Analysis Using Peripheral Blood Lymphocytes Facilitates the Identification of a Large Deletion Mutation: Molecular Diagnosis of an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency.

Clinical heterogeneity of neonatal intrahepatic cholestasis caused by citrin deficiency: case reports from 16 patients

Genotypic and Phenotypic Features of Citrin Deficiency: Five-Year Experience in A Chinese Pediatric Center

Prenatal Diagnosis Of Citrin Deficiency In A Chinese Family With A Fatal Proband

Multiple ovarian antral follicles in a preterm infant with neonatal intrahepatic cholestasis caused by citrin deficiency: A clinical, genetic and transcriptional analysis

Identification of a LargeSLC25A13Deletion Via Sophisticated Molecular Analyses Using Peripheral Blood Lymphocytes in an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency (NICCD): A Clinical and Molecular Study